Cancer Incidence and Mortality for Essex County, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 256.6 418.0 394.0-443.3 141.8 466.5 431.3-504.4 114.8 380.7 347.4-416.7 100.6 155.4 141.6-170.4 54.6 183.2 161.7-207.4 46.0 137.5 119.0-158.7
Oral cavity and pharynx 4.8 7.6 4.8-12.0 3.2 11.0 6.1-18.9 1.6 4.3 1.9-10.2 0.6 1.0 0.2-3.6 0.6 2.1 0.4-7.4 0.0 0.0 0.0-4.9
Esophagus 5.2 7.8 5.1-12.0 3.8 11.5 6.9-19.0 1.4 4.3 1.7-10.4 4.0 6.0 3.7-9.9 3.0 10.2 5.7-17.8 1.0 2.5 0.8-7.9
Stomach 3.8 5.7 3.4-9.5 3.4 10.7 6.1-18.2 0.4 1.2 0.2-6.4 0.6 1.0 0.2-3.7 0.4 1.4 0.1-6.5 0.2 0.6 0.0-5.7
Colorectal 19.8 35.9 28.6-44.7 9.4 36.1 25.8-49.5 10.4 35.2 25.5-47.9 8.4 14.2 10.0-19.9 4.4 16.3 10.0-25.6 4.0 12.1 7.0-20.4
Colon excluding rectum 14.8 25.9 19.9-33.4 5.6 21.3 13.6-32.3 9.2 30.3 21.6-42.0 6.4 11.3 7.5-16.6 3.4 13.2 7.5-22.1 3.0 9.4 4.9-17.3
Rectum & rectosigmoid 5.0 10.0 6.2-15.4 3.8 14.8 8.6-24.2 1.2 4.9 1.5-12.2 2.0 2.9 1.4-6.1 1.0 3.0 1.0-8.4 1.0 2.7 0.9-8.2
Liver / intrahepatic bile duct 5.6 8.6 5.6-13.1 3.4 10.9 6.3-18.5 2.2 7.0 3.1-14.5 3.4 5.3 2.9-9.1 2.0 6.2 2.9-12.5 1.4 5.0 1.7-12.1
Pancreas 7.8 13.1 9.0-18.6 4.2 14.6 8.6-23.6 3.6 11.2 6.4-19.1 7.0 11.4 7.8-16.4 3.6 12.2 6.9-20.4 3.4 10.5 6.1-18.2
Larynx 2.0 3.1 1.5-6.4 1.4 4.4 1.7-10.3 0.6 1.9 0.4-7.3 0.8 1.4 0.4-4.2 0.6 2.0 0.4-7.3 0.2 0.7 0.0-5.7
Lung and bronchus 40.4 61.2 52.8-71.0 19.0 61.8 49.6-76.6 21.4 63.0 51.2-77.5 27.4 42.0 35.1-50.2 13.6 45.3 35.0-58.2 13.8 41.6 31.9-54.2
Melanoma of the skin 13.0 22.2 16.8-29.0 9.4 33.6 24.2-45.9 3.6 11.9 6.9-20.2 2.2 3.2 1.6-6.4 1.8 6.3 2.8-12.8 0.4 0.9 0.1-5.9
Female breast             29.0 99.4 82.4-119.3             5.0 14.0 8.9-22.2
Cervix uteri             1.6 8.8 3.4-18.5             0.6 2.7 0.4-9.5
Corpus uterus and NOS             7.6 25.6 17.8-36.5             1.4 3.7 1.5-9.4
Ovary             2.2 7.0 3.3-14.1             2.6 9.4 4.5-17.8
Prostate       31.8 91.2 77.3-107.6             4.4 15.4 9.6-24.1      
Testis       1.2 6.0 2.1-13.7             0.2 1.1 0.0-6.4      
Urinary bladder (incl. in situ) 16.8 26.4 20.9-33.2 13.8 46.9 36.3-60.4 3.0 8.4 4.7-15.3 2.8 4.0 2.2-7.3 2.0 6.9 3.3-13.6 0.8 1.8 0.5-7.0
Kidney and renal pelvis 7.4 11.5 8.0-16.4 5.4 17.7 11.5-26.8 2.0 5.3 2.5-11.4 2.0 2.9 1.4-6.1 1.6 4.9 2.1-10.8 0.4 1.1 0.1-6.2
Brain and other central nervous system 2.4 3.5 1.8-6.7 1.4 4.1 1.6-9.8 1.0 2.9 0.9-8.5 2.6 4.3 2.2-8.0 1.6 5.3 2.2-11.5 1.0 3.5 0.9-10.1
Thyroid 4.4 10.4 6.2-16.4 1.2 5.8 1.9-13.6 3.2 15.3 8.2-26.2 0.0 0.0 0.0-2.3 0.0 0.0 0.0-4.4 0.0 0.0 0.0-4.9
Hodgkin lymphoma 1.0 3.6 1.2-8.3 0.2 1.0 0.0-6.1 0.8 6.6 1.8-16.2 0.2 0.3 0.0-2.7 0.2 0.6 0.0-5.1 0.0 0.0 0.0-4.9
Non-Hodgkin lymphomas 12.8 20.5 15.6-26.9 7.2 23.2 16.0-33.1 5.6 18.8 11.9-28.8 3.4 4.9 2.8-8.4 2.2 6.9 3.4-13.4 1.2 3.5 1.3-9.3
Myeloma 3.6 4.9 2.9-8.4 2.6 7.7 4.0-14.3 1.0 2.5 0.8-7.8 1.6 2.1 0.9-4.9 0.6 1.7 0.3-6.7 1.0 2.6 0.8-8.0
Leukemias 8.2 13.5 9.4-19.1 5.2 18.6 11.7-28.6 3.0 8.2 4.6-15.0 4.0 5.8 3.5-9.5 2.2 6.8 3.4-13.4 1.8 4.8 2.2-10.8

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.